←Back to Expert Scholars
Translational Medicine / 转化医学Lung Cancer Immunotherapy
Edward B. Garon
MD, MS
🏢University of California Los Angeles🌐USA
Professor of Medicine, Director Thoracic Oncology
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Edward Garon led KEYNOTE-001 which provided the earliest large-scale evidence for pembrolizumab efficacy in non-small cell lung cancer and reported landmark five-year survival outcomes. He directs thoracic oncology at UCLA and has shaped the long-term understanding of PD-1 therapy.
Share:
🧪Research Fields 研究领域
KEYNOTE-001
pembrolizumab NSCLC
long-term immunotherapy outcomes
biomarker-driven trials
thoracic oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Edward B. Garon 的研究动态
Follow Edward B. Garon's research updates
留下邮箱，当我们发布与 Edward B. Garon（University of California Los Angeles）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment